Craig A. Magaret

Increased HIV-1 vaccine efficacy against viruses with genetic signatures in Env V2

Morgane Rolland, Paul T. Edlefsen, Brendan B. Larsen et al. · Nature · 2012 · 420 citations · Full text

Vaccination, Viral Evolution, Genetic Signatures +10

Genetic impact of vaccination on breakthrough HIV-1 sequences from the STEP trial

Morgane Rolland, Sodsai Tovanabutra, Allan C. deCamp et al. · Nature Medicine · 2011 · 226 citations

Vaccination, Medicine, Human Retrovirus +11

The Thai Phase III HIV Type 1 Vaccine Trial (RV144) Regimen Induces Antibodies That Target Conserved Regions Within the V2 Loop of gp120

Nicos Karasavvas, Erik Billings, Mangala Rao et al. · AIDS Research and Human Retroviruses · 2012 · 210 citations · Full text

Vaccination, Hiv-1 Acquisition, Antibody Responses +12

Recurrent Signature Patterns in HIV-1 B Clade Envelope Glycoproteins Associated with either Early or Chronic Infections

S. Gnanakaran, Tanmoy Bhattacharya, Marcus Daniels et al. · PLoS Pathogens · 2011 · 124 citations · Full text

Neutralization titer biomarker for antibody-mediated prevention of HIV-1 acquisition

Peter B. Gilbert, Yunda Huang, Allan C. deCamp et al. · Nature Medicine · 2022 · 105 citations · Full text